semaglutide and liver damage Wegovy treated a serious form of disease in about two-thirds of patients in a major clinical trial, according to findings published in the New England Journal of Medicine Active ingredient in weight loss

Novo Nordisk announced that the FDA has approved Ozempic (semaglutide injection) to reduce the risk of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to

Novartis ~$30B+ dealmaking to strengthen pipeline New drug launches driving growth Heavy investment in oncology + cardiovascular Trend: More capital more late-stage assets rising demand for clinical leadership

Wondering can I do my ozempic shot a day early

This Review outlines the current landscape of obesity drug development, focusing on glucagon-like peptide 1 receptor agonists, multi-receptor agonists, amylin receptor agonists and next-generation oral therapies

However, peptides are readily broken down during digestion which is why Ozempic (approved for diabetes) and Wegovy (just a higher dose of semaglutide approved for weight loss) have to be injected